Take a look at the top midday traders.

Walgreens — The drug store chain fell about 5% after the company reported its quarterly results. It did not increase its year-end forecast, despite recording an improvement in earnings. The president of the company said that Covid testing demand has slowened since January and that it may take some time before its healthcare investments can pay off.

Baidu — Shares for the tech company tumbled roughly 7%. Baidu was included to the Securities and Exchange Commission’s U.S.-traded China stock list. The stocks could be removed if the search engine fails to report financial audits to U.S. regulators.

AMD — The chipmaker lost 7.1% after Barclays downgradedIt lowered the target price from $148 – $115 and made it equal-weight. Bank cited “cyclical risks across multiple end markets,” which included PC and gaming, as reasons for the downgrade.

Dell TechnologiesAnd HP — Shares of the computer equipment companies fell after Morgan Stanley downgradedDell to be at the same weight as HP and HP to be below. The reasons the bank downgraded were attributed to ongoing macro uncertainty, and “cautious” hardware outlook. HP lost 5%, and Dell dropped 5.4%.

PVH — Shares of the Calvin Klein parent fell 6.4% after Morgan Stanley downgradedStock should not be more than half its weight. The firm stated that the stock should remain within a range for the moment.

Amylyx Pharmaceuticals — The stock lost 13.5% after a Food and Drug Administration panel voted to not recommend the approval of an experimental ALS drug developed by Amylyx. Panel members stated that there was no evidence to support the claim of effectiveness in fighting the disease from the study data.

Occidental Petroleum — Shares rallied about 2% after CEO Vicki Hollub purchased 14,191 of her own company’s shares. After the purchase of 14,191 shares by Vicki Hollub, CEO of her company, shares rose about 2%. Warren Buffett’s recent buying spreeIn the stock of outperforming energy stocks

UBS — The bank’s stock rose 1.2% after Goldman Sachs initiatedUBS is rated buy by analysts. Goldman believes that fintech’s rise is good news for banks.

— CNBC’s Tanaya Macheel, Sarah Min and Samantha Subin contributed reporting